14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Mar 18, 2024 Sell 2 345 Krick Anthony J Common Stock
Mar 18, 2024 Sell 15 059 Marino Michael F Iii Common Stock
Mar 18, 2024 Sell 19 198 Mahmoud Ramy A Common Stock
Mar 15, 2024 Buy 3 816 Marino Michael F Iii Common Stock
Mar 15, 2024 Buy 6 114 Mahmoud Ramy A Common Stock
Feb 28, 2024 Buy 112 500 Krick Anthony J Common Stock
Feb 28, 2024 Buy 56 250 Krick Anthony J Stock Option (Right to Buy)
Feb 28, 2024 Buy 252 675 Spence Paul Jr. Common Stock
Feb 28, 2024 Buy 126 338 Spence Paul Jr. Stock Option (Right to Buy)
Feb 28, 2024 Buy 280 000 Marino Michael F Iii Common Stock
Feb 28, 2024 Buy 140 000 Marino Michael F Iii Stock Option (Right to Buy)
Feb 28, 2024 Buy 795 975 Mahmoud Ramy A Common Stock
Feb 28, 2024 Buy 397 988 Mahmoud Ramy A Stock Option (Right to Buy)
Jan 31, 2024 Sell 52 875 Mahmoud Ramy A Common Stock
Dec 18, 2023 Sell 11 114 Mahmoud Ramy A Common Stock
Dec 18, 2023 Sell 5 005 Marino Michael F Iii Common Stock
Dec 15, 2023 Buy 6 113 Mahmoud Ramy A Common Stock
Dec 15, 2023 Buy 3 817 Marino Michael F Iii Common Stock
Sep 18, 2023 Sell 11 083 Mahmoud Ramy A Common Stock
Sep 18, 2023 Sell 4 991 Marino Michael F Iii Common Stock
Sep 15, 2023 Buy 6 113 Mahmoud Ramy A Common Stock
Sep 15, 2023 Buy 3 817 Marino Michael F Iii Common Stock
Jun 16, 2023 Sell 1 516 Marino Michael F Iii Common Stock
Jun 16, 2023 Sell 3 543 Mahmoud Ramy A Common Stock
Jun 15, 2023 Buy 3 816 Marino Michael F Iii Common Stock
Jun 15, 2023 Buy 6 114 Mahmoud Ramy A Common Stock
Jun 08, 2023 Buy 53 500 Helton Sandra L Stock Option (Right to Buy)
Jun 08, 2023 Buy 53 500 Bednarski Eric Stock Option (Right to Buy)
Jun 08, 2023 Buy 53 500 Dempsey Kyle Stock Option (Right to Buy)
Jun 08, 2023 Buy 53 500 Fletcher R John Stock Option (Right to Buy)
Jun 08, 2023 Buy 53 500 Groenhuysen Wilhelmus Cm Stock Option (Right to Buy)
Jun 08, 2023 Buy 53 500 Heyman Tomas J. Stock Option (Right to Buy)
Jun 08, 2023 Buy 53 500 Owen Catherine E. Stock Option (Right to Buy)
May 12, 2023 Buy 48 370 Avista Capital Partners Ii Gp, Llc Common Stock
May 12, 2023 Sell 10 102 707 Avista Capital Partners Ii Gp, Llc Common Stock
May 12, 2023 Sell 807 995 Avista Capital Partners Ii Gp, Llc Common Stock
Mar 16, 2023 Sell 4 972 Marino Michael F Iii Common Stock
Mar 16, 2023 Sell 11 040 Mahmoud Ramy A Common Stock
Mar 15, 2023 Buy 3 817 Marino Michael F Iii Common Stock
Mar 15, 2023 Buy 6 113 Mahmoud Ramy A Common Stock
Mar 08, 2023 Buy 154 375 Marino Michael F Iii Common Stock
Mar 08, 2023 Buy 185 250 Marino Michael F Iii Stock Option (Right to Buy)
Mar 08, 2023 Buy 50 750 Krick Anthony J Stock Option (Right to Buy)
Mar 08, 2023 Buy 33 833 Krick Anthony J Common Stock
Jan 30, 2023 Buy 549 202 Mahmoud Ramy A Stock Option (Right to Buy)
Jan 30, 2023 Buy 336 135 Mahmoud Ramy A Common Stock
Jan 13, 2023 Sell 5 241 Marino Michael F Iii Common Stock
Jan 13, 2023 Sell 8 148 Mahmoud Ramy A Common Stock
Jan 13, 2023 Sell 29 664 Miller Peter K Common Stock
Dec 16, 2022 Sell 2 751 Marino Michael F Iii Common Stock
Dec 16, 2022 Sell 1 015 Janis Michele Common Stock
Dec 16, 2022 Sell 3 208 Clavelli Victor M Common Stock
Dec 16, 2022 Sell 15 253 Miller Peter K Common Stock
Dec 15, 2022 Buy 3 817 Marino Michael F Iii Common Stock
Dec 15, 2022 Buy 1 333 Janis Michele Common Stock
Dec 15, 2022 Buy 2 500 Clavelli Victor M Common Stock
Dec 15, 2022 Buy 6 113 Mahmoud Ramy A Common Stock
Dec 15, 2022 Sell 7 507 Mahmoud Ramy A Common Stock
Dec 15, 2022 Buy 10 850 Miller Peter K Common Stock
Dec 15, 2022 Buy 500 000 Spence Paul Jr. Stock Option (Right to Buy)
Dec 15, 2022 Buy 0 Spence Paul Jr.
Dec 15, 2022 Buy 0 Spence Paul Jr.
Nov 23, 2022 Buy 2 105 263 Mvm Partners, Llc Warrant (right to buy)
Sep 20, 2022 Sell 1 151 Marino Michael F Iii Common Stock
Sep 20, 2022 Sell 406 Janis Michele Common Stock
Sep 20, 2022 Sell 832 Clavelli Victor M Common Stock
Sep 20, 2022 Sell 2 945 Mahmoud Ramy A Common Stock
Sep 20, 2022 Sell 5 226 Miller Peter K Common Stock
Sep 16, 2022 Sell 1 583 Marino Michael F Iii Common Stock
Sep 16, 2022 Sell 1 332 Janis Michele Common Stock
Sep 16, 2022 Sell 2 356 Clavelli Victor M Common Stock
Sep 16, 2022 Sell 23 663 Mahmoud Ramy A Common Stock
Sep 16, 2022 Sell 48 225 Miller Peter K Common Stock
Sep 15, 2022 Buy 3 816 Marino Michael F Iii Common Stock
Sep 15, 2022 Buy 1 333 Janis Michele Common Stock
Sep 15, 2022 Buy 2 500 Clavelli Victor M Common Stock
Sep 15, 2022 Buy 6 113 Mahmoud Ramy A Common Stock
Sep 15, 2022 Buy 10 850 Miller Peter K Common Stock
Jun 15, 2022 Buy 86 800 Miller Peter K Common Stock
Jun 15, 2022 Sell 51 744 Miller Peter K Common Stock
Jun 15, 2022 Buy 48 907 Mahmoud Ramy A Common Stock
Jun 15, 2022 Sell 28 074 Mahmoud Ramy A Common Stock
Jun 15, 2022 Buy 30 534 Marino Michael F Iii Common Stock
Jun 15, 2022 Sell 10 793 Marino Michael F Iii Common Stock
Jun 15, 2022 Buy 20 000 Clavelli Victor M Common Stock
Jun 15, 2022 Sell 9 008 Clavelli Victor M Common Stock
Jun 15, 2022 Buy 10 667 Janis Michele Common Stock
Jun 15, 2022 Sell 3 849 Janis Michele Common Stock
Jun 10, 2022 Buy 42 500 Krick Anthony J Stock Option (Right to Buy)
Jun 10, 2022 Buy 0 Janis Michele Common Stock
Jun 10, 2022 Buy 18 879 Janis Michele Stock Option (Right to Buy)
Jun 10, 2022 Buy 42 758 Janis Michele Stock Option (Right to Buy)
Jun 10, 2022 Buy 37 542 Janis Michele Stock Option (Right to Buy)
Jun 10, 2022 Buy 35 000 Janis Michele Stock Option (Right to Buy)
Jun 10, 2022 Buy 20 000 Janis Michele Stock Option (Right to Buy)
Jun 10, 2022 Buy 27 500 Janis Michele Stock Option (Right to Buy)
Jun 08, 2022 Buy 32 000 Heyman Tomas J. Stock Option (Right to Buy)
Jun 08, 2022 Buy 32 000 Heyman Tomas J. Stock Option (Right to Buy)
Jun 08, 2022 Buy 32 000 Helton Sandra L Stock Option (Right to Buy)
Jun 08, 2022 Buy 32 000 Owen Catherine E. Stock Option (Right to Buy)
INSIDER POWER
-22.246
Last 100 transactions
Buy: 7 147 366 | Sell: 11 317 417 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be negative at a ratio of -22.246.

In total, the insiders bought 7 147 366 and sold 11 317 417 OPTN shares in the last 100 trades.

Click to get the best stock tips daily for free!

About OptiNose Inc.

OptiNose. OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb c... OPTN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT